VIM and pulmonary fibrosis: Furthermore, treatment with citrullinated vimentin mediates development and progression of lung fibrosis through Toll-Like Receptor 4 (TLR4)-dependent nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) activation in mice8.